Abstract
Background
COVID-19 may present with a variety of clinical syndromes, however, the upper airway and the lower respiratory tract are the principle sites of infection. Previous work on respiratory viral infections demonstrated that airway inflammation results in the release of volatile organic compounds as well as nitric oxide. The detection of these gases from patients’ exhaled breath offers a novel potential diagnostic target for COVID-19 that would offer real-time screening of patients for COVID-19 infection.
Methods and findings
We present here a breath tester utilizing a catalytically active material, which allows for the temporal manifestation of the gaseous biomarkers’ interactions with the sensor, thus giving a distinct breath print of the disease. A total of 46 Intensive Care Unit (ICU) patients on mechanical ventilation participated in the study, 23 with active COVID-19 respiratory infection and 23 non-COVID-19 controls. Exhaled breath bags were collected on ICU days 1, 3, 7, and 10 or until liberation from mechanical ventilation. The breathalyzer detected high exhaled nitric oxide (NO) concentration with a distinctive pattern for patients with active COVID-19 pneumonia. The COVID-19 “breath print” has the pattern of the small Greek letter omega (). The “breath print” identified patients with COVID-19 pneumonia with 88% accuracy upon their admission to the ICU. Furthermore, the sensitivity index of the breath print (which scales with the concentration of the key biomarker ammonia) appears to correlate with duration of COVID-19 infection.
Conclusions
The implication of this breath tester technology for the rapid screening for COVID-19 and potentially detection of other infectious diseases in the future.
Funder
Division of Chemical, Bioengineering, Environmental, and Transport Systems
Publisher
Public Library of Science (PLoS)
Reference26 articles.
1. Novel Isoprene Sensor for a Flu Virus Breath Monitor;PI Gouma;Sensors-Basel,2017
2. WHO. WHO Director-General’s opening remarks at the media briefing on COVID-19–11 March 2020 2020. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020.
3. Coronaviruses: an overview of their replication and pathogenesis;AR Fehr;Methods Mol Biol,2015
4. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer;S Tian;J Thorac Oncol,2020
5. CDC. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19): CDC; 2021 [updated 2/12/2021]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献